« Back to overview

FIP interventions at the 134th WHO Executive Board in Geneva

FIP made several interventions during the 2014 WHO Executive Board both on behalf of FIP and on behalf of WHPA.


The FIP in its interventions promotes the role of pharmacists and pharmacists’ organisations. FIP has made an intervention at the WHO EB on Global Strategy and targets for tuberculosis prevention, care and control after 2015.  FIP and the global community of pharmacists renewed today their commitment and their support to ensure that TB prevention, care and control will continue and further improve beyond 2015.

FIP also highlighted the efforts of the local associations of pharmacists, such as in India, where community pharmacists with a specific training are referring suspected cases to medical centers, raising awareness on TB among the population as well as to serving as a DOTs centers. This example and many others clear demonstrate the contribution of pharmacists in achieving this strategy.  Read the full intervention here.

The intervention on WHO Engagement with non-State actors was joint, done on behalf WHPA. Read the full intervention here.

The FIP intervention on counterfeit (SSFFC) medicines highlighted, that manufacturing, importing, distributing, supplying, selling and dispensing of counterfeit products can be facilitated when the required supervision by healthcare professional or the authorities is deficient. Read the full intervention here.

FIP’s intervention on Access to essential medicines underlined the complex challenge of accessing vulnerable medicines when on shortage, which affects both developed and developing countries. The FIP Report on International Summit on Medicine Shortage (June 2013, Toronto) concluded in a series of six recommendations to address the phenomenon of medicine shortage, including a recommendation to develop of the list of critical and vulnerable medicines, as it will identify essential medicines at risk of becoming in shortage. Read the full statement here.